Olgu Sunumu
BibTex RIS Kaynak Göster

Yıl 2020, Cilt: 2 Sayı: 2, 48 - 50, 29.04.2020

Cihan Semet Seray Türe Suat Akgür Abdulmecit Yildiz Alparslan Ersoy

https://doi.org/10.46310/tjim.691092

Öz

Teşekkür

Prof. Dr. Alparslan ERSOY'a destekleri için teşekkür ederim.

Kaynakça

  • 1. Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8.
  • 2. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis. 2008 Jul;10(4):260-8.
  • 3. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008 Feb;115(2 Suppl):S3-12. doi: 10.1016/j.ophtha.2007.10.009.
  • 4. Pavan-Langston D. Herpes zoster ophthalmicus. Neurology. 1995 Dec;45(12 Suppl 8):S50-1.
  • 5. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982 Sep;61(5):310-6.
  • 6. Mary A Albrecht MA, Levin MJ. Epidemiology, clinical manifestations, and diagnosis of herpes zoster. In: Hirsch MS, Mitty J, editors. UpToDate [Internet]. Waltham (MA): UpToDate Inc; 2020 [cited 2020 Feb]. Available from: https://www.uptodate.com/contents/ epidemiology-clinical-manifestations-and-diagnosis-of-herpes.
  • 7. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007 Nov;82(11):1341-9.
  • 8. Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997 Jun 9;157(11):1209-13.
  • 9. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004 Jan;4(1):108-15.
  • 10. Lauzurica R, Bayés B, Frías C, Fontseré N, Hernandez A, Matas L, Jimenez A, Bonet J, Romero R. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc. 2003 Aug;35(5):1758-9.
  • 11. Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. Medicine (Baltimore). 2016 Apr;95(14):e3304. doi: 10.1097/MD.0000000000003304.
  • 12. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002 Jul 4;347(1):26-34.
  • 13. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007 Mar 29;356(13):1338-43.
  • 14. Ostermann ME, Gyawali P, Snowden SA, Eastwood JB, Streather CP. A 67-year-old kidney transplant patient with headache of uncertain origin. Nephrol Dial Transplant. 2002 Mar;17(3):508-10.

Herpes zoster ophthalmicus infection after kidney transplantation

Yıl 2020, Cilt: 2 Sayı: 2, 48 - 50, 29.04.2020

Cihan Semet Seray Türe Suat Akgür Abdulmecit Yildiz Alparslan Ersoy

https://doi.org/10.46310/tjim.691092

Öz

Herpes zoster causes an acute dermatomal infection with vesicular rash associated with reactivation of the Varicella zoster virus. The infection usually involves the thoracic, cervical, ophthalmic and lumbosacral regions. Herpes zoster infection is common after solid organ transplantation. Herpes zoster ophthalmicus is a rare form of Herpes zoster infection and involves the ophthalmic branch of the trigeminal nerve along the V1-V2 dermatomes. Herein, we reported a kidney recipient who developed Herpes zoster ophthalmicus infection after transplantation.

Anahtar Kelimeler

Herpes zoster kidney transplantation infection

Kaynakça

  • 1. Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8.
  • 2. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis. 2008 Jul;10(4):260-8.
  • 3. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008 Feb;115(2 Suppl):S3-12. doi: 10.1016/j.ophtha.2007.10.009.
  • 4. Pavan-Langston D. Herpes zoster ophthalmicus. Neurology. 1995 Dec;45(12 Suppl 8):S50-1.
  • 5. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982 Sep;61(5):310-6.
  • 6. Mary A Albrecht MA, Levin MJ. Epidemiology, clinical manifestations, and diagnosis of herpes zoster. In: Hirsch MS, Mitty J, editors. UpToDate [Internet]. Waltham (MA): UpToDate Inc; 2020 [cited 2020 Feb]. Available from: https://www.uptodate.com/contents/ epidemiology-clinical-manifestations-and-diagnosis-of-herpes.
  • 7. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007 Nov;82(11):1341-9.
  • 8. Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997 Jun 9;157(11):1209-13.
  • 9. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004 Jan;4(1):108-15.
  • 10. Lauzurica R, Bayés B, Frías C, Fontseré N, Hernandez A, Matas L, Jimenez A, Bonet J, Romero R. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc. 2003 Aug;35(5):1758-9.
  • 11. Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. Medicine (Baltimore). 2016 Apr;95(14):e3304. doi: 10.1097/MD.0000000000003304.
  • 12. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002 Jul 4;347(1):26-34.
  • 13. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007 Mar 29;356(13):1338-43.
  • 14. Ostermann ME, Gyawali P, Snowden SA, Eastwood JB, Streather CP. A 67-year-old kidney transplant patient with headache of uncertain origin. Nephrol Dial Transplant. 2002 Mar;17(3):508-10.
Toplam 14 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular İç Hastalıkları
Bölüm Case Reports
Yazarlar

Cihan Semet 0000-0003-2210-820X

Seray Türe Bu kişi benim 0000-0001-6164-5695

Suat Akgür 0000-0003-1745-6744

Abdulmecit Yildiz 0000-0001-5941-9103

Alparslan Ersoy 0000-0002-0710-0923

Yayımlanma Tarihi 29 Nisan 2020
Gönderilme Tarihi 19 Şubat 2020
Kabul Tarihi 21 Nisan 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 2 Sayı: 2

Kaynak Göster

EndNote Semet C, Türe S, Akgür S, Yildiz A, Ersoy A (01 Nisan 2020) Herpes zoster ophthalmicus infection after kidney transplantation. Turkish Journal of Internal Medicine 2 2 48–50.
 Kapak Resmi İndir

e-ISSN: 2687-4245 

Turkish Journal of Internal Medicine, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png
2023 -TJIM.org